Technical Analysis for AUTL - Autolus Therapeutics plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.80 | -5.08% | -0.15 |
AUTL closed down 5.08 percent on Wednesday, November 20, 2024, on 1.59 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -5.08% | |
| NR7 | Range Contraction | -5.08% | |
| Narrow Range Bar | Range Contraction | -5.08% | |
| New 52 Week Low | Weakness | -5.08% | |
| Wide Bands | Range Expansion | -5.08% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| Down 5% | about 18 hours ago |
| Down 3% | about 22 hours ago |
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 2 % | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Autolus Therapeutics Ltd is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Treatment Of Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Treatment Of Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.45 |
| 52 Week Low | 2.74 |
| Average Volume | 1,520,160 |
| 200-Day Moving Average | 4.46 |
| 50-Day Moving Average | 3.83 |
| 20-Day Moving Average | 3.58 |
| 10-Day Moving Average | 3.27 |
| Average True Range | 0.31 |
| RSI (14) | 31.51 |
| ADX | 23.33 |
| +DI | 15.81 |
| -DI | 27.40 |
| Chandelier Exit (Long, 3 ATRs) | 3.77 |
| Chandelier Exit (Short, 3 ATRs) | 3.66 |
| Upper Bollinger Bands | 4.65 |
| Lower Bollinger Band | 2.52 |
| Percent B (%b) | 0.13 |
| BandWidth | 59.34 |
| MACD Line | -0.30 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.0857 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.19 | ||||
| Resistance 3 (R3) | 3.21 | 3.11 | 3.13 | ||
| Resistance 2 (R2) | 3.11 | 3.01 | 3.10 | 3.10 | |
| Resistance 1 (R1) | 2.95 | 2.95 | 2.90 | 2.93 | 3.08 |
| Pivot Point | 2.85 | 2.85 | 2.82 | 2.84 | 2.85 |
| Support 1 (S1) | 2.69 | 2.75 | 2.64 | 2.67 | 2.52 |
| Support 2 (S2) | 2.59 | 2.69 | 2.58 | 2.50 | |
| Support 3 (S3) | 2.43 | 2.59 | 2.48 | ||
| Support 4 (S4) | 2.41 |
